Results 71 to 80 of about 6,313 (203)
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims Integrating a diabetes management system (DMS) and personal coaching in patient care may reduce the burden of type 2 diabetes (T2DM) on patients and help address the multifaceted challenges associated with diabetes management. This study aims to assess the impact of the DMS with online coaching in patients with T2DM on changes in HbA1c ...
Marlo Verket +21 more
wiley +1 more source
Diabetes, Obesity and Metabolism, EarlyView.Abstract Aims Diabetic ketoacidosis (DKA) is a serious complication of diabetes, requiring intravenous (IV) insulin until resolution and subsequent transition to subcutaneous insulin. Currently, clinical guidelines vary regarding the timing of long‐acting subcutaneous insulin initiation, with some advocating early administration during IV insulin ...
Bachviet Nguyen +4 more
wiley +1 more source
Frontiers in EndocrinologyBackgroundUltra-long-acting insulin analogs [insulin degludec (IDeg) and insulin glargine 300 units/mL (IGla-300)] offer a longer duration of action with less risk of hypoglycemia compared to other long-acting insulins.
Eman N. Alhmoud +3 more
doaj +1 more source
Managing feline diabetes: current perspectives [PDF]
, 2018 Diabetes mellitus is a common endocrine disease in cats. While type 2 diabetes is the most common form seen in cats, other underlying causes may contribute to insulin resistance.
Gottlieb, Susan, Rand, Jacquie
core +1 more source
Strategies to Improve the Lipophilicity of Hydrophilic Macromolecular Drugs
Advanced Healthcare Materials, Volume 15, Issue 5, 2 February 2026.Hydrophilic macromolecular drugs can be successfully lipidized by covalent attachment of lipids, by hydrophobic ion pairing with negatively or positively charged surfactants, and by dry or wet reverse micelle formation. Lipophilicity enhancement of hydrophilic macromolecules has several benefits including stability and bioavailability improvement ...
Sera Lindner +8 more
wiley +1 more source
Indian Journal of Endocrinology and Metabolism, 2013 Basal insulin have been developed over the years. In recent times newer analogues have been added to the armanentarium for diabetes therapy.
S V Madhu, M Velmurugan
doaj +1 more source
Inpatient glycemic variability and long-term mortality in hospitalized patients with type 2 diabetes [PDF]
, 2016 Aims/Hypothesis: To determine the association between inpatient glycemic variability and long-term mortality in patients with type 2 diabetes mellitus. Methods: Capillary blood glucose (CBG) of inpatients from 8 hospitals was analysed.
Cunningham, Scott G. +3 more
core +2 more sources
Modern basal insulin analogs: An incomplete story
Indian Journal of Endocrinology and Metabolism, 2014 The currently available basal insulin does not completely mimic the endogenous insulin secretion. This has continued to promote the search for ideal basal insulin.
Awadhesh Kumar Singh +1 more
doaj +1 more source
When intensive insulin therapy (MDi) fails in patients with type 2 diabetes: Switching to GLP-1 receptor agonist versus insulin pump [PDF]
, 2016 Treatment with insulin, alone or with oral or injectable hypoglycemic agents, is becoming increasingly common in patients with type 2 diabetes. However, approximately 40% of patients fail to reach their glycemic targets with the initially prescribed ...
Castaneda, Javier +4 more
core +2 more sources